Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11655289 Pharmaceutical compositions containing anti-beta amyloid antibodies

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Biogen
Biogen
0
Date Filed
August 22, 2018
0
Date of Patent
May 23, 2023
0
Patent Applicant
Biogen
Biogen
0
Patent Application Number
16639338
0
Patent Citations
‌
US Patent 7964192 Prevention and treatment of amyloidgenic disease
0
‌
US Patent 8022268 Transgenic animal model for alzheimer's disease
0
‌
US Patent 8034339 Prevention and treatment of amyloidogenic disease
0
‌
US Patent 8128928 Humanized antibodies that recognize beta amyloid peptide
0
‌
US Patent 8263558 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
0
‌
US Patent 8389226 Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
0
‌
US Patent 8703126 Reduced-viscosity concentrated protein formulations
0
‌
US Patent 8753610 Methods for diagnosing CNS disorders with fusion antibodies that cross the blood-brain barrier in both directions
0
‌
US Patent 8906367 Method of providing disease-specific binding molecules and targets
0
‌
US Patent 9670272 Method of providing disease-specific binding molecules and targets
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11655289
0
Patent Primary Examiner
‌
Yunsoo Kim
0

Find more entities like US Patent 11655289 Pharmaceutical compositions containing anti-beta amyloid antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo